Fetal heart testing in high-risk pregnancies after baby loss
Part of Blood & lymphatic, Bones, joints & muscles, Genetic & congenital, Heart & circulation, Immune system & allergy, Women’s health & pregnancy clinical trials.
This study checks unborn babies’ heart signals using special scans during pregnancy and then checks the baby’s heart shortly after birth. It may help researchers understand why certain high-risk pregnancies can lead to fetal demise and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and currently pregnant
- Your pregnancy fits one risk group: prior unexplained stillbirth after 20 weeks, major heart defect, hydrops, gastroschisis, or a monochorionic twin pregnancy
- You can read, speak, and sign consent in English
- You can sit/recline comfortably for 1–3 hours (with breaks if needed)
- You’re willing to do all study heart tests: fetal magnetocardiogram (fMCG) at set weeks and a newborn ECG after delivery (unless medically unsafe)
- You agree the research team can review your and your baby’s pregnancy, delivery, and baby records to confirm the diagnosis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to measure and understand an unborn baby’s heart rhythm using special ultrasound/electrical testing. It may help doctors better evaluate abnormal or possibly abnormal fetal heart rates.
This study looks at how to improve care for babies with serious heart defects, both before and after birth. It brings together pregnancy and newborn care to help identify and treat these heart problems as early as possible.
This study tests new ways to monitor pregnancies to help prevent stillbirth. It involves two groups: one starting around 12 weeks and another starting at 28 weeks if there are signs of possible growth problems or less fetal movement.
This study tests if remote monitoring of your baby's heartbeat from home is a safe and effective option for high-risk pregnancies. It may reduce the need for frequent hospital visits.
This study follows pregnant women who have congenital heart disease (a heart problem present from birth). The goal is to monitor how both mother and baby are doing, which can help improve care for others in the same situation.
This trial lets you monitor your baby's heartbeat at home with a simple device instead of coming to the hospital each time. It's for women with certain high-risk pregnancy conditions who are 32 weeks or more along.
Hear when a new Congenital Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.